Guest: Lawrence Cohen, PhD
Host: Bruce Japsen
A treatment for atherosclerosis and the chronic inflammation in arterial blood vessels could be entering critical clinical trial stages that may result in a novel new treatment. Dr. Lawrence Cohen, president and chief executive officer of VIA Pharmaceuticals lays out for host Chicago Tribune's Bruce Japsen the landscape of large pharmaceutical companies as well as smaller biotech companies that are making progress in bringing these treatments through the clinical trial process. They are closer than you might think.
Clinician's Roundtable